Antihistamine effects on prefrontal cortex activity during working memory process in preschool children: A near-infrared spectroscopy (NIRS) study

Neuroscience Research

Volumn 67, Issue 1, 2010, Pages 80-85

  Tsujii, Takeo ^a   Yamamoto, Eriko ^a   Ohira, Takayuki ^b   Takahashi, Takao ^b   Watanabe, Shigeru ^b  

^a Center for Advanced Research on Logic and Sensibility (CARLS)   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Antihistamine; Epinastine; Histamine; Ketotifen; Near infrared spectroscopy (NIRS); Preschool children; Working memory

Indexed keywords

EPINASTINE; HEMOGLOBIN; KETOTIFEN; PLACEBO;

ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; NEAR INFRARED SPECTROSCOPY; NEUROIMAGING; NORMAL HUMAN; PREFRONTAL CORTEX; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SPATIAL MEMORY; WORKING MEMORY;

CHILD; CHILD, PRESCHOOL; DIBENZAZEPINES; HEMOGLOBINS; HISTAMINE H1 ANTAGONISTS; HUMANS; IMIDAZOLES; KETOTIFEN; MEMORY, SHORT-TERM; OXYHEMOGLOBINS; PREFRONTAL CORTEX; SPECTROSCOPY, NEAR-INFRARED;

EID: 77952885363     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.01.010     Document Type: Article

References (46)

1. Allen P.P., Cleare A.J., Lee F., Fusar-Poli P., Tunstall N., Fu C.H., Brammer M.J., McGuire P.K. Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology 2006, 187:486-497.
2. Boas D.A., Dale A.M., Franceschini M.A. Diffuse optical imaging of brain activation: approaches to optimizing image sensitivity, resolution, and accuracy. Neuroimage 2004, 23:S275-S288.
3. Capuron L., Welberg L., Heim C., Wagner D., Solomon L., Papanicolaou D.A., Craddock R.C., Miller A.H., Reeves W.C. Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology 2006, 31:1777-1784.
4. Chee M.W., Chuah L.Y., Venkatraman V., Chan W.Y., Philip P., Dinges D.F. Functional imaging of working memory following normal sleep and after 24 and 35h of sleep deprivation: correlations of fronto-parietal activation with performance. Neuroimage 2006, 31:419-428.
5. Choo W.C., Lee W.W., Venkatraman V., Sheu F.S., Chee M.W. Dissociation of cortical regions modulated by both working memory load and sleep deprivation and by sleep deprivation alone. Neuroimage 2005, 25:579-587.
6. Clark V.P., Fannon S., Lai S., Benson R., Bauer L. Responses to rare visual target and distractor stimuli using event-related fMRI. J. Neurophysiol. 2000, 83:3133-3139.
7. Donchin E. Surprise!...Surprise?. Psychophysiology 1981, 18:493-513.
8. Elliott P.B. Appendix 1: tables of d′. Signal Detection and Recognition by Human Observers 1964, 659-678. Wiley, New York. J.A. Swets (Ed.).
9. Folstein M.F., Luria R. Reliability, validity, and clinical application of the Visual Analogue Mood Scale. Psychol. Med. 1973, 3:479-486.
10. Gevins A., Smith M.E., McEvoy L.K. Tracking the cognitive pharmacodynamics of psychoactive substances with combinations of behavioral and neurophysiological measures. Neuropsychopharmacology 2002, 26:27-39.
11. Hindmarch I., Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin. Exp. Allergy 1999, 3:133-142.
12. Hock C., Stormer R., Dursteler K., Muller-Spahn F., Ladewig D., Stohler R. Heroin-induced deoxygenation of cerebral hemoglobin: monitoring by means of near-infrared spectroscopy. Ann. Neurol. 1999, 45:134-135.
13. Ishigaki T., Tanno Y. The signal detection ability of patients with auditory hallucination: analysis using the continuous performance test. Psychiatry Clin. Neurosci. 1999, 53:471-476.
14. Jacobsen L.K., Pugh K.R., Mencl W.E., Gelernter J. C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology 2006, 188:530-540.
15. Jager G., de Win M.M., Vervaeke H.K., Schilt T., Kahn R.S., van den Brink W., van Ree J.M., Ramsey N.F. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain functions in a prospective fMRI study. Psychopharmacology 2007, 193:403-414.
16. Lieberman H.R., Tharion W.J., Shukitt-Hale B., Speckman K.L., Tulley R. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Psychopharmacology 2002, 164:250-261.
17. Maki A., Yamashita Y., Ito Y., Watanabe E., Mayanagi Y., Koizumi H. Spatial and temporal analysis of human motor activity using noninvasive NIR topography. Med. Phys. 1995, 22:1997-2005.
18. Michiels V., Cluydts R. Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr. Scand. 2001, 103:84-93.
19. Minagawa-Kawai Y., Mori K., Hebden J.C., Dupoux E. Optical imaging of infants' neurocognitive development: recent advances and perspectives. Dev. Neurobiol. 2008, 68:712-728.
20. Mochizuki H., Tashiro M., Tagawa M., Kano M., Itoh M., Okamura N., Watanabe T., Yanai K. The effects of a sedative antihistamine, d-chlorpheniramine, on visuomotor spatial discrimination and regional brain activity as measured by positron emission tomography (PET). Hum. Psychopharmacol. 2002, 17:413-418.
21. 11C]doxepin. Nucl. Med. Biol. 2004, 31:165-171.
22. Mu Q., Nahas Z., Johnson K.A., Yamanaka K., Mishory A., Koola J., Hill S., Horner M.D., Bohning D.E., George M.S. Decreased cortical response to verbal working memory following sleep deprivation. Sleep 2005, 28:55-67.
23. Ng K.H., Chong D., Wong C.K., Ong H.T., Lee C.Y., Lee B.W., Shek L.P. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics 2004, 113:e116-e121.
24. Obata A., Morimoto K., Sato H., Takeshita T., Kawaguchi H., Koizumi H., Maki A. Effects of alcohol on hemodynamic and cardiovascular reaction in different genotypes. Psychiatry Res. 2005, 139:65-72.
25. Okamoto M., Dan H., Sakamoto K., Takeo K., Shimizu K., Kohno S., Oda I., Isobe S., Suzuki T., Kohyama K., Dan I. Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10-20 system oriented for transcranial functional brain mapping. Neuroimage 2004, 21:99-111.
26. Shamsi Z., Hindmarch I. Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum. Psychopharmacol. 2000, 15:S3-S30.
27. Shields B.J., Cohen D.M., Harbeck-Weber C., Powers J.D., Smith G.A. Pediatric pain measurement using a visual analogue scale: a comparison of two teaching methods. Clin. Pediatr. 2003, 42:227-234.
28. Simons F.E., Fraser T.G., Reggin J.D., Roberts J.R., Simons K.J. Adverse central nervous system effects of older antihistamines in children. Pediatr. Allergy Immunol. 1996, 7:22-27.
29. 1-receptor antagonists) terfenadine and chlorpheniramine in children. J. Pediatr. 1994, 124:979-983.
30. 1-antihistaminic activity of cetirizine and fexofenadine in allergic children. Pediatr. Allergy Immunol. 2003, 14:207-211.
31. Simons F.E., Simons K.J. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years. J. Allergy Clin. Immunol. 2005, 116:355-361.
32. Smith E.E., Jonides J. Neuroimaging analyses of human working memory. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:12061-12068.
33. 1-receptor antagonist cetirizine on the behavioral, cognitive, and psychomotor development of very young children with atopic dermatitis. Pediatr. Res. 2002, 52:251-257.
34. Tashiro M., Horikawa E., Mochizuki H., Sakurada Y., Kato M., Inokuchi T., Ridout F., Hindmarch I., Yanai K. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. Hum. Psychopharmacol. 2005, 20:501-509.
35. (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen. Br. J. Clin. Pharmacol. 2006, 61:16-26.
36. 11C-doxepin positron emission tomography. J. Clin. Pharmacol. 2004, 44:890-900.
37. Theunissen E.L., Jonkman L.M., Kuypers K.P., Ramaekers J.G. A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. J. Psychopharmacol. 2006, 20:496-505.
38. Theunissen E.L., Vermeeren A., Ramaekers J.G. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br. J. Clin. Pharmacol. 2006, 61:79-86.
39. Theunissen E.L., van Kroonenburgh M.J., van Deursen J.A., Blom-Coenjaerts C., Ramaekers J.G. Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis. Psychopharmacology 2006, 187:95-102.
40. Thomas R.J. Fatigue in the executive cortical network demonstrated in narcoleptics using functional magnetic resonance imaging-a preliminary study. Sleep Med. 2005, 6:399-406.
41. 1 antagonists on cognitive tasks: behavioral and near-infrared spectroscopy (NIRS) examinations. Psychopharmacology 2007, 194:83-91.
42. Tsujimoto S., Yamamoto T., Kawaguchi H., Koizumi H., Sawaguchi T. Prefrontal cortical activation associated with working memory in adults and preschool children: an event-related optical topography study. Cereb. Cortex 2004, 14:703-712.
43. Tukey, J.W., 1953. The problem of multiple comparisons. Unpublished manuscript on file with: Princeton University, Firestone Library, Princeton, p. 396.
44. Turner C., Handford A.D., Nicholson A.N. Sedation and memory: studies with a histamine H-1 receptor antagonist. J. Psychopharmacol. 2006, 20:506-517.
45. Yanai K., Tashiro M. The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacol. Ther. 2007, 113:1-15.
46. Yoshiura T., Zhong J., Shibata D.K., Kwok W.E., Shrier D.A., Numaguchi Y. Functional MRI study of auditory and visual oddball tasks. Neuroreport 1999, 10:1683-1688.